SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DECODE GENETICS-*DCGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (262)10/9/2006 2:21:33 PM
From: DewDiligence_on_SI  Read Replies (1) of 313
 
Remember that the two molecules hit two different -- related, but quite different -- targets. Why do you think the sales of one would cannibalize the other?

It seems like a reasonable assumption—two biological pathways does not mean two indications. Why would they not cannibalize one another?

Might the effects be additive? Might they treat [different] patient populations?

Possible, but is this likely? Not likely enough, IMO, for DCGN to want to bet on both programs even if they had the money to do so.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News